Results 131 to 140 of about 3,525,902 (283)
, 1981 Newsletter dedicated to traveling in Texas, including information about news, locations, and events of interest to visitors as well as statistics and summaries of travel in the ...
Texas. Travel and Information Division.
core +1 more source
Molecular Oncology, EarlyView.Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
, 1987 Newsletter dedicated to traveling in Texas, including information about news, locations, and events of interest to visitors as well as statistics and summaries of travel in the ...
Texas. Travel and Information Division.
core
Spatial biology in cancer epigenetics
Molecular Oncology, EarlyView.Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source
, 2006 Tourist map with roads emphasized. Relief shown by gradient tints and spot heights. Depths shown by gradient tints. Includes notes, indexes of places, publisher's index map, publisher's map list, and color illustrations.Color;1:2,400 ...
International Travel Maps (Firm);
core
Psychological and Social Aspects of Vaccination Hesitancy-Implications for Travel Medicine in the Aftermath of the COVID-19 Crisis: A Narrative Review. [PDF]
Medicina (Kaunas), 2023 Milionis C +3 more
europepmc +2 more sources
Travel Medicine and the Travel Industry [PDF]
Wilderness & Environmental Medicine, 2006 openaire +2 more sources
Molecular Oncology, EarlyView.This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source